These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11172532)

  • 41. Risk assessment and serotonin: Animal models and human psychopathologies.
    Blanchard DC; Meyza K
    Behav Brain Res; 2019 Jan; 357-358():9-17. PubMed ID: 28705471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stress and affective disorders in humans.
    Paykel ES
    Semin Clin Neuropsychiatry; 2001 Jan; 6(1):4-11. PubMed ID: 11172528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can a systems approach produce a better understanding of mood disorders?
    Plant N
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3335-3344. PubMed ID: 27565355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A possible role of neuropeptide Y in depression and stress.
    Morales-Medina JC; Dumont Y; Quirion R
    Brain Res; 2010 Feb; 1314():194-205. PubMed ID: 19782662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The circadian basis of mood disorders: recent developments and treatment implications.
    Monteleone P; Maj M
    Eur Neuropsychopharmacol; 2008 Oct; 18(10):701-11. PubMed ID: 18662865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subclinical psychopathology and socio-economic status in unaffected twins discordant for affective disorder.
    Christensen MV; Kyvik KO; Kessing LV
    J Psychiatr Res; 2007; 41(3-4):229-38. PubMed ID: 16563437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project.
    Williams LM; Goldstein-Piekarski AN; Chowdhry N; Grisanzio KA; Haug NA; Samara Z; Etkin A; O'Hara R; Schatzberg AF; Suppes T; Yesavage J
    BMC Psychiatry; 2016 Mar; 16():68. PubMed ID: 26980207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of Diurnal Rodents in the Research of Depression.
    Bilu C; Einat H; Kronfeld-Schor N
    Drug Dev Res; 2016 Nov; 77(7):336-345. PubMed ID: 27654112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evolutionary concepts of affective disorders].
    Rybakowski F; Rybakowski J
    Psychiatr Pol; 2006; 40(3):401-13. PubMed ID: 17037808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A susceptibility gene for affective disorders and the response of the human amygdala.
    Hariri AR; Drabant EM; Munoz KE; Kolachana BS; Mattay VS; Egan MF; Weinberger DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):146-52. PubMed ID: 15699291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensory modulation and affective disorders in children and adolescents with Asperger's disorder.
    Pfeiffer B; Kinnealey M; Reed C; Herzberg G
    Am J Occup Ther; 2005; 59(3):335-45. PubMed ID: 15969281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circadian genes, rhythms and the biology of mood disorders.
    McClung CA
    Pharmacol Ther; 2007 May; 114(2):222-32. PubMed ID: 17395264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder.
    Kato T; Ishiwata M; Yamada K; Kasahara T; Kakiuchi C; Iwamoto K; Kawamura K; Ishihara H; Oka Y
    Neurosci Res; 2008 Jun; 61(2):143-58. PubMed ID: 18343518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Animal models of major depression and their clinical implications.
    Czéh B; Fuchs E; Wiborg O; Simon M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():293-310. PubMed ID: 25891248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
    Hess C; Reif A; Strobel A; Boreatti-Hümmer A; Heine M; Lesch KP; Jacob CP
    J Neural Transm (Vienna); 2009 Feb; 116(2):121-30. PubMed ID: 18982239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selectively bred rodents as models of depression and anxiety.
    Wegener G; Mathe AA; Neumann ID
    Curr Top Behav Neurosci; 2012; 12():139-87. PubMed ID: 22351423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide y: role in emotion and alcohol dependence.
    Carvajal C; Dumont Y; Quirion R
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):181-95. PubMed ID: 16611091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches.
    Balmus IM; Ciobica A; Antioch I; Dobrin R; Timofte D
    Oxid Med Cell Longev; 2016; 2016():3975101. PubMed ID: 27563374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Affective temperaments: unique constructs or dimensions of normal personality by another name?
    Kwapil TR; DeGeorge D; Walsh MA; Burgin CJ; Silvia PJ; Barrantes-Vidal N
    J Affect Disord; 2013 Dec; 151(3):882-90. PubMed ID: 24011729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.